# Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis

> **NCT03236961** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Turku University Hospital** · enrollment: 552 (estimated)

## Conditions studied

- Acute Appendicitis

## Interventions

- **DRUG:** Ertapenem
- **DRUG:** Moxifloxacin

## Key facts

- **NCT ID:** NCT03236961
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-04-03
- **Primary completion:** 2018-11-27
- **Final completion:** 2029-04-01
- **Target enrollment:** 552 (ESTIMATED)
- **Last updated:** 2020-11-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03236961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03236961, "Optimizing the Antibiotic Treatment of Uncomplicated Acute Appendicitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03236961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*